Longitudinal, Prospective, French, Multicenter Cohort Study on Pancreatic Radiofrequency
Recruiting · NCT05871164 · Observational (researchers observe without assigning treatment) · Lead sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche
View the official record on ClinicalTrials.gov →Interventions studied
Pancreatic radiofrequency
What this trial is about
The purpose of the study is to evaluate the oncological efficacy of pancreatic radiofrequency by the objective response rate (complete and partial responses according to RECIST 1.1.), 5 years after the end of treatment.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Age ≥ 18 years old;
- Patient to be treated for a pancreatic tumor by ultrasound-guided RF with a fine needle;
- Indication of pancreatic radiofrequency validated in a Multidisciplinary Consultation Meeting;
- Patient able to understand the information related to the study;
- Patient accepting study follow-up visits;
- Patient having been informed and agreeing to participate in the study.
Exclusion criteria
- Patient with a contraindication to radiofrequency treatment;
- Pregnant or breastfeeding women
Where it is running
1 location listed.
- CHI Toulon La Seyne - Toulon, France